Author | Teresa McNulty

Articles

New Phase 3 data advances pursuit of pediatric indication for Xarelto

July 16, 2019

Janssen, a pharmaceutical subsidiary of Johnson & Johnson, has announced plans to pursue a pediatric indication for its best-selling blood thinner, Xarelto (rivaroxaban).